机构：[1]Transfusion Department, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu 610072, China四川省人民医院[2]School of Medical and Life Sciences, Reproductive and Women-Children Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China[3]College of Medicine, Southwest Jiaotong University, Chengdu, Sichuan 611756, China[4]Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, China四川省人民医院[5]Division of Endocrinology and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, Sichuan, China f四川大学华西医院[6]Unit´e de Biologie Fonctionnelle et Adaptative, Universit´e de Paris, Paris 75013, France[7]Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu 610072, China四川省人民医院[8]Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China[9]Renal Department and Nephrology Institute, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Sichuan Clinical Research Center for Kidney Diseases, Chengdu 610072, China四川省人民医院
This work was supported by the National Natural Science Foundation of China (No 82073311, 2021); Natural Science Foundation of Sichuan Province (No.2022JDTD0025, 2022); Key Research and Development Program of Science and Technology Department of Sichuan Province (No.2019YFS0514, 2019); the Key R & D projects in Sichuan Province (No.2020YFS0399, 2020).
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类|2 区医学
小类|1 区药学2 区医学：研究与实验
最新[2023]版：
大类|2 区医学
小类|1 区药学2 区医学：研究与实验
JCR分区：
出版当年[2022]版：
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
最新[2023]版：
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构：[1]Transfusion Department, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu 610072, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Nian Qing,Li Jingwei,Han ZhongYu,et al.SPARC in hematologic malignancies and novel technique for hematological disease with its abnormal expression[J].BIOMEDICINE & PHARMACOTHERAPY.2022,153:doi:10.1016/j.biopha.2022.113519.
APA：
Nian Qing,Li Jingwei,Han ZhongYu,Liang Qi,Liu Maoyu...&Shi Jianyou.(2022).SPARC in hematologic malignancies and novel technique for hematological disease with its abnormal expression.BIOMEDICINE & PHARMACOTHERAPY,153,
MLA：
Nian Qing,et al."SPARC in hematologic malignancies and novel technique for hematological disease with its abnormal expression".BIOMEDICINE & PHARMACOTHERAPY 153.(2022)
医学